{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T20:53:43Z","timestamp":1648587223685},"reference-count":22,"publisher":"Baishideng Publishing Group Inc.","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.5228","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T21:51:58Z","timestamp":1257371518000},"page":"5228","source":"Crossref","is-referenced-by-count":4,"title":["A case of advanced intrahepatic cholangiocarcinomasuccessfully treated with chemosensitivity test-guidedsystemic chemotherapy"],"prefix":"10.3748","volume":"15","author":[{"given":"Kazumichi","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Wakatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Katsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Monoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Yokokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005;41:5-15.","DOI":"10.1002\/hep.20537"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Hezel AF, Zhu AX. Systemic therapy for biliary tract cancers. Oncologist 2008;13:415-423.","DOI":"10.1634\/theoncologist.2007-0252"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Furukawa T, Kubota T, Suto A, Takahara T, Yamaguchi H, Takeuchi T, Kase S, Kodaira S, Ishibiki K, Kitajima M. Clinical usefulness of chemosensitivity testing using the MTT assay. J Surg Oncol 1991;48:188-193.","DOI":"10.1002\/jso.2930480310"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Yamaue H, Tanimura H, Noguchi K, Hotta T, Tani M, Tsunoda T, Iwahashi M, Tamai M, Iwakura S. Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay. Br J Cancer 1992;66:794-799.","DOI":"10.1038\/bjc.1992.362"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kawamura H, Ikeda K, Takiyama I, Terashima M. The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer. Eur J Cancer 1997;33:960-966.","DOI":"10.1016\/S0959-8049(97)00075-0"},{"key":"ref6","unstructured":"Kondo T, Kubota T, Tanimura H, Yamaue H, Akiyama S, Maehara Y, Tanigawa N, Kitajima M, Takagi H. Cumulative results of chemosensitivity tests for antitumor agents in Japan. Japan Research Society for Appropriate Cancer Chemotherapy. Anticancer Res 2000;20:2389-2392."},{"key":"ref7","unstructured":"Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 1987;47:943-946."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Crouch SP, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 1993;160:81-88.","DOI":"10.1016\/0022-1759(93)90011-U"},{"key":"ref9","unstructured":"Andreotti PE, Cree IA, Kurbacher CM, Hartmann DM, Linder D, Harel G, Gleiberman I, Caruso PA, Ricks SH, Untch M. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res 1995;55:5276-5282."},{"key":"ref10","unstructured":"Kangas L, Grönroos M, Nieminen AL. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 1984;62:338-343."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-517; discussion 517-519.","DOI":"10.1097\/00000658-200110000-00010"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Farley DR, Weaver AL, Nagorney DM. \"Natural history\" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-429.","DOI":"10.4065\/70.5.425"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Patel T, Singh P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol 2007;23:317-323.","DOI":"10.1097\/MOG.0b013e3280495451"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Glimelius B, Hoffman K, Sjödén PO, Jacobsson G, Sellström H, Enander LK, Linné T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7:593-600.","DOI":"10.1093\/oxfordjournals.annonc.a010676"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Penz M, Kornek GV, Raderer M, Ulrich-Pur H, Fiebiger W, Lenauer A, Depisch D, Krauss G, Schneeweiss B, Scheithauer W. Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Ann Oncol 2001;12:183-186.","DOI":"10.1023\/A:1008352123009"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Tsavaris N, Kosmas C, Gouveris P, Gennatas K, Polyzos A, Mouratidou D, Tsipras H, Margaris H, Papastratis G, Tzima E. Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer. Invest New Drugs 2004;22:193-198.","DOI":"10.1023\/B:DRUG.0000011797.09549.53"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 2004;91:1769-1774.","DOI":"10.1038\/sj.bjc.6602208"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Scanlon KJ, Newman EM, Lu Y, Priest DG. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986;83:8923-8925.","DOI":"10.1073\/pnas.83.23.8923"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Kim YJ, Im SA, Kim HG, Oh SY, Lee KW, Choi IS, Oh DY, Lee SH, Kim JH, Kim DW. A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer. Ann Oncol 2008;19:99-103.","DOI":"10.1093\/annonc\/mdm439"},{"key":"ref20","unstructured":"Shimada M, Takenaka K, Kawahara N, Yamamoto K, Shirabe K, Maehara Y, Sugimachi K. Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors. Hepatogastroenterology 1996;43:1159-1164."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ieta K, Tanaka F, Utsunomiya T, Kuwano H, Mori M. CEACAM6 gene expression in intrahepatic cholangiocarcinoma. Br J Cancer 2006;95:532-540.","DOI":"10.1038\/sj.bjc.6603276"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"He XR, Wu XP. Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro. Chin Med Sci J 2008;23:54-59.","DOI":"10.1016\/S1001-9294(09)60011-0"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i41\/5228.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:18:11Z","timestamp":1558613891000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i41\/5228.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":22,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.5228","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}